Marpai appointed Damien Lamendola as its new CEO, replacing Edmundo Gonzalez, co-founder and now former CEO. Lamendola has been on Marpai’s board of directors since April 2021, and he will remain on the Board. He is also the largest beneficial shareholder of the company. In addition, Steve Johnson will be joining Marpai as CFO, joining Lamendola on the company’s management team, and replacing the company’s current CFO, Yoram Bibring. Additionally, Mike Dendy, a healthcare industry veteran, will be joining the Board. Lamendola founded WellDyne, a pharmacy benefit manager, in 2002, which he sold to the private equity firm, The Carlyle Group, in 2016. He is also the founder of Continental Benefits, a third-party administrator, which was sold to Marpai in 2021. Lamendola is also the CEO of HillCour Holding, an investment firm with holdings in various healthcare companies. Mike Dendy built HPS Paradigm Administrators into one of the preeminent TPA’s in the country before selling it in 2004. He then founded and built Advanced Medical Pricing Solutions. He is now CEO of CarynHealth.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
